1,2-Dichloroethane → HCID 68274458, compound
Reaction equation
C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.[CH3:15][N:16]1[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]1.CCN(CC)CC.[CH2:29]([O:31][C:32]([C:34]1[C:39]([O:40][CH2:41][CH3:42])=[C:38]([N:43]2[CH2:48][CH2:47][O:46][CH2:45][CH2:44]2)[N:37]=[C:36]([C:49]2[CH:54]=[CH:53][C:52]([NH:55][C:56]([NH:58][C:59]3[CH:64]=[CH:63][C:62]([C:65]([OH:67])=O)=[CH:61][CH:60]=3)=[O:57])=[CH:51][CH:50]=2)[N:35]=1)=[O:33])[CH3:30]>CN(C=O)C>[CH2:29]([O:31][C:32]([C:34]1[C:39]([O:40][CH2:41][CH3:42])=[C:38]([N:43]2[CH2:48][CH2:47][O:46][CH2:45][CH2:44]2)[N:37]=[C:36]([C:49]2[CH:54]=[CH:53][C:52]([NH:55][C:56]([NH:58][C:59]3[CH:64]=[CH:63][C:62]([C:65]([N:19]4[CH2:20][CH2:21][N:16]([CH3:15])[CH2:17][CH2:18]4)=[O:67])=[CH:61][CH:60]=3)=[O:57])=[CH:51][CH:50]=2)[N:35]=1)=[O:33])[CH3:30]Participants
7
Procedure
EDC (53.7 mg, 1.5 eq.), HOBT (42.9 mg, 1.5 eq.), 1-methyl-piperazine (0.03 ml, 1.5 eq.) and Et3N (0.053 ml, 2.0 eq.) were added to a stirred solution of 2-{4-[3-(4-carboxy-phenyl)-ureido]-phenyl}-5-ethoxy-6-morpholin-4-yl-pyrimidine-4-carboxylic acid ethyl ester (80 mg, 1 eq.) in dry DMF (2 ml) and the mixture reacted overnight at r.t. The mixture was quenched with H2O, extracted with EA, and washed with brine. The crude was purified by chromatography to give a product (34.5 mg, 30%).
Workup
- customthe mixture reacted overnight at r.t
- customThe mixture was quenched with H2O
- extractionextracted with EA
- washwashed with brine
- customThe crude was purified by chromatography
Sources & evidence
- ORD record
- ord-20d2657d4f3a458cb31165437bddc1a3
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09315491B2
Reaction notes
Loading…